The Poland Diabetes Devices Market is expected to witness growth from $132 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.65% for the forecasted year 2022-2030. Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market is segmented by type and by the end user. Some key players in this market include Skamex, SORIMEX, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
The Poland Diabetes Devices Market is at around $132 Mn in 2022 and is projected to reach $238 Mn in 2030, exhibiting a CAGR of 7.65% during the forecast period. Poland spend 6.6% of its GDP on healthcare in 2022, an increase from the prior year. Currently, about 5% of health expenditure is made up of out-of-pocket expenses, and 8% of people choose to purchase voluntary health insurance. 2020 health spending in Poland is $1347 per person.23. Public funding only covers 72% of expenses, which is lower than the 79% average across the EU. The relatively expensive out-of-pocket expense (22%) raises accessibility concerns.
In Poland, there were about 3.1 million people who had diabetes in 2021, a prevalence rate of about 8.1%. By 2045, 3.7 million people are anticipated to be living in this area. Between 2015 and 2021, there was a 33% rise in diabetes diagnoses in Poland. In Poland, there were 186,000 new cases of diabetes in 2021, equating to a prevalence rate of about 480 new cases per 100,000 people. In order to monitor blood glucose levels, blood glucose metres are commonly used in Poland. With the aid of these tools, diabetics can check their blood sugar levels at home or while on the go, enabling them to make educated choices about their food, exercise routine, and medication. The management of diabetes is made simpler for individuals with diabetes by the availability in Poland of many blood glucose metres with extra features like memory storage, data management software, and Bluetooth connectivity. Polish people frequently check their blood sugar levels using lancets and test strips. When combined with CGM or blood glucose meters, these instruments are frequently used.
Market Growth Drivers
Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market for diabetes devices is anticipated to rise as the population ages. Technological developments in diabetes management are the main drivers of the diabetes device industry in Poland. It is becoming possible to measure blood sugar levels with wearable technology, and insulin delivery systems with more precise dosing are also being created. It is anticipated that these technical developments will increase the demand for diabetes devices in Poland. Diabetes is becoming more common in Poland, which is anticipated to increase demand for diabetes devices there. The market for diabetes devices like blood glucose meters, insulin pumps, and CGM devices is anticipated to rise as more people are receiving diabetes diagnoses.
Market Restraints
It can be difficult for producers of expensive products to compete in Poland's sizable market for low-cost diabetes devices. People with diabetes who cannot afford more expensive devices may choose these less expensive options instead, which may reduce the demand for more expensive products and have an adverse effect on sales for the makers.
Key Players
The Polish Ministry of Health and the Polish Agency for Health Technology Assessment and Tariff System (AOTMiT) are in charge of overseeing the healthcare policies and regulatory environment in Poland's market for diabetes devices. The European Union (EU) rules serve as the foundation for Poland's regulatory framework for diabetes devices. In Poland, the licensing, marketing, and distribution of medical devices, including diabetes devices, are governed by the Medical Devices Act and the Ordinance of the Minister of Health on Medical Devices. Before marketing and distributing their goods in Poland, the regulations mandate that diabetes device manufacturers acquire the necessary certifications and approvals from regulatory authorities. In Poland, the market for diabetes devices is also impacted by the reimbursement system in addition to the regulatory structure. In Poland, payment for medical equipment, including diabetes devices, is handled by the National Health Fund (NFZ). But not all diabetes equipment is covered by the NFZ, and some equipment might require co-payments or cost-sharing agreements. The NFZ has established reimbursement standards that manufacturers of diabetes devices must satisfy in order for their products to be covered.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents
By End User (Revenue, USD Billion):
The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.